Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib in moderate to severe psoriasis
NCT01006096Phase 2Withdrawn
- Sponsor
- Northwestern University
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in psoriasis, sponsored by Northwestern University. Status: withdrawn.
02
Drugs
erlotinib
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT01006096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01006096.